[Burkitt's lymphosarcoma in a child with HIV infection]

Area of Science:

• Pediatric Oncology
• Infectious Diseases
• Hematology

Background:

• Human Immunodeficiency Virus (HIV) infection is a known risk factor for various cancers, including lymphomas.
• Co-infection with Hepatitis B Virus (HBV) can complicate the clinical course of HIV-infected individuals.
• Burkitt's lymphosarcoma is an aggressive non-Hodgkin lymphoma.

Observation:

• A 4-year-old girl with a history of perinatal HIV and HBV infection presented with Burkitt's lymphosarcoma.
• The patient acquired HIV and HBV infections at 1 year and 4 months of age.
• Clinical presentation and diagnosis of Burkitt's lymphosarcoma were established.

Findings:

• Treatment attempts using high-dose prednisolone, vincristine, and cyclophosphamide showed no therapeutic effect.
• The aggressive nature of Burkitt's lymphosarcoma in the context of advanced immunodeficiency was observed.
• Resistance to standard chemotherapeutic agents was noted.

Implications:

• This case highlights the challenges in treating aggressive pediatric lymphomas in immunocompromised hosts.
• Further research into novel therapeutic strategies for HIV-associated Burkitt's lymphosarcoma is warranted.
• The importance of early diagnosis and management of co-infections in pediatric HIV is underscored.